Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.405 EUR | -0.71% | -2.43% | -7.87% |
05-15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
05-14 | Medigene Ag Maintains Earnings Guidance for 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.87% | 37.52M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene Boosts Share Capital Via Rights Offering, Private Placement